Funding Round
Neuralify closes €58M Series C to expand AI EEG diagnostic platform across Europe
Les Echos3/29/2026·03/29/26🌐 Europe
Summary
Paris-based Neuralify raised €58M Series C led by Cathay Innovation, with Bpifrance, Elaia Partners, and Servier Ventures. The company's AI EEG diagnostic platform is now deployed in 120 hospitals across 18 countries and processes 2 million EEG studies per year. Funds support US FDA regulatory submission and Asian market entry.
Why it matters
Neuralify has achieved a scale rarely seen in clinical AI — 2 million annual EEG readings across 120 hospitals gives them the network effects and data advantages that are very difficult for new entrants to replicate. US FDA submission is the key to unlocking the largest market.
#AI Diagnostics#EEG#Neurodiagnostics#Epilepsy#France
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in